Abstract
The study aimed to compare the outcomes of treating patients with widespread soft tissue phlegmon complicated by sepsis using cryosupernatant plasma and freshly frozen plasma. A total of 61 sepsis-diagnosed patients were involved in the study, divided into two groups. Group 1 received complex treatment with cryosupernatant plasma (CSNP), while group 2 received fresh frozen plasma (FFP). The use of CSNP in the complex treatment of septic patients, as opposed to FFP, resulted in improved treatment outcomes, reduced progression of multiple organ failure, prevention of thrombotic and thromboembolic complications, decreased mortality, and faster normalization of hemocoagulation and fibrinolysis system indicators.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
